Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
OXIGENE Add to My Watchlist (NSDQ: OXGN) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Oxigene 1.30 +0.06 (+4.84%) 249,799
230 Third Avenue
Waltham, MA 02451 US
(781) 547-5900
(781) 547-6800 fax
www.oxigene.com
CEO Dr. Peter J. Langecker, M.D., Ph.D.
Auditor Ernst & Young LLP
Exchange Traded NQ
ISIN Number US6918281071
CIK Number 908259
NAICS Code 325414
Business Summary
A clinical-stage biopharmaceutical company, which develops novel therapeutics to treat cancer and eye diseases.
Number of Employees 34
Share Fundamentals
Market Cap 81.20M
Shares Outstanding 62.46M
Float 60.48M
Short Interest 2.95M
Financial Strength
Revenue (TTM) N/A
Earnings (TTM) -$28,706,000
Quick Ratio 2.8:1
Current Ratio 2.9:1
Total Debt/Equity 0:1
Profitability
Gross Margin N/A
EBITDA Margin N/A
Profit Margin N/A
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs